Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
New tests launched in October - Insights
In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Improving diagnosis and treatment of Helicobacter pylori - Insights
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
Communiqué Archives - Page 2 of 4 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 2 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 3 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 4 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Our experts discuss the latest from Mayo Clinic Laboratories, so you can stay up to date on the most advanced diagnostics and newly developed tests. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web...
A Test in Focus Archives - Insights
Skip to Content MayoACCESS MayoLINK...